Cardiology 1995: The Rise of Stents and Statins

Tricia Ward


May 27, 2015

In This Article

The Golden Era of Innovation

Twenty years ago, Bill Clinton was President, Newt Gingrich was TIME magazine's man of the year, and interventional cardiology was in its infancy. In celebration of the 20th anniversary of Medscape, we perused the cardiovascular literature from 1995 and canvassed some experts by email for their reflections on the time and how far the field has come

Cardiologists were grappling with many of the same issues that perplex today's doctors albeit with earlier iterations of devices and drugs—angioplasty vs surgery, evolving stent designs, who should get statins, to name a few. A presentation at the American Heart Association (AHA) meeting in 1995 was titled "Acute Coronary Syndromes (ACS): Is It Safe to Stent?"

Dr Steven E. Nissen

Dr E. Magnus Ohman (Duke Medical Center, Durham, North Carolina) observed that "The 1990s was a golden era of innovation and investigation for ACS. Since then we have mostly fine-tuned the field." Dr Gregg Stone (Columbia University Medical Center, New York, New York) remarked that "the advances we've seen in technology, technique, imaging, and pharmacotherapy have been nothing short of amazing".

"It has been an amazing 20 years," agreed Dr Steven Nissen (Cleveland Clinic, Cleveland, Ohio), adding that "mortality rates have steadily fallen with widespread usage of primary and secondary prevention strategies."


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: